OSD
Developing an appropriate stability testing program to produce clear quality data is essential to getting a drug to market. As the complexity of the molecules entering the drug pipeline increases so to does the demand for specific expertise surrounding stability testing and meeting regulatory requirements. As a result, more and more companies are looking to third parties, like Recipharm, to carry out high quality, complex stability studies to accelerate their drugs to market.
Ramesh Jagadeesan Ph.D, Senior Director – Analytical Development at Recipharm